< back

MACUSTAR

Dry age-related macular degeneration: Development of novel clinical endpoints for clinical trials with a regulatory and patient access intention

The major objective is to develop novel clinical endpoints for clinical trials with a regulatory and patient access intention in patients with intermediate age-related macular degeneration (iAMD). Additional objectives are to characterise visual impairment in iAMD and its progression, as well as identify risk factors for progression to late stage AMD.

Population: adult | Intervention type: non-interventional study

Trial website

ClinicalTrials.gov

#Ophthalmology

Publications

Disease-specific assessment of Vision Impairment in Low Luminance in age-related macular degeneration - a MACUSTAR study report

Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention—MACUSTAR.

Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study